Dorman Products (NASDAQ: DORM) reported Q1 EPS of $1.04, in-line with the analyst estimate of $1.04. Revenue for the quarter came in at $288 million versus the consensus estimate of $292 million.

GUIDANCE:

Dorman Products sees FY2021 EPS of $4.40-$4.60, versus the consensus of $4.49.

• For fiscal 2021, the Company expects net sales growth between 9%-12%, diluted EPS of between $4.32 and $4.52, and adjusted diluted EPS* of between $4.40 and $4.60.

For earnings history and earnings-related data on Dorman Products (DORM) click here.